We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Deepmatter Group Plc | LSE:DMTR | London | Ordinary Share | GB00B29YYY86 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0325 | 0.025 | 0.04 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
26/10/2022 08:11 | P73 is terrible dog | zxie | |
26/10/2022 08:05 | With only £700k cash as of 30/09/2022 the company would be reckless not to use today's rise to issue further equity for working capital purposes. This will come down as the brokers forward sell placing shares. | pwhite73 | |
26/10/2022 08:04 | I see this was ca. 3p only 2 years ago. This multi-year deal could easily make the difference methinks. | andrbea | |
26/10/2022 07:57 | You thinking to much | zxie | |
26/10/2022 07:52 | meanwhile. some are making nice profits rather than listening to placing deramps which no one knows when will come. | babbler | |
26/10/2022 07:49 | Enjoy the placing at 0.1p that's if they can get it. | wololol | |
26/10/2022 07:25 | DeepMatter Group Plc (AIM: DMTR, "Deepmatter", the "Group"), the digital chemistry data and software company, announces that after the nine months of the financial year and having now signed a material agreement with Merck (see separate statement), the Group expects revenue for the current financial year to be no less than GBP1.5m, an increase of over 50% year on year (2021: GBP1.0m).DeepMatter has secured three strategically important multi-year collaborations during the current financial year and as anticipated continues to see a strengthening of its sales pipeline following a strong first half. The Merck collaboration has the potential to become one of the Group's largest to date. | zen12 | |
26/10/2022 07:24 | Multi year licensing agreement with Merck, and you derampers think they're done lol | zen12 | |
26/10/2022 07:12 | Guess that's your opinion to have. | babbler | |
26/10/2022 07:05 | Back down to sub 0.1 . 3 months cash in the bank. Will struggle to raise money like last time 90% discount. . Let them go bust | wololol | |
26/10/2022 07:02 | Very nice news today. And update. | babbler | |
30/8/2022 06:51 | Friday afternoon RNS sneaked in with David Norwood increasing his holding. | swashbuck1er | |
17/8/2022 09:56 | I'm still here with a few worth about tuppence | jpuff | |
15/8/2022 10:30 | No there are two of us! | pilkersa | |
09/8/2022 15:38 | is there any cash left? LOL | jimbren | |
09/8/2022 15:31 | is there any cash left? LOL | jimbren | |
04/8/2022 07:30 | Am I the only investor left? Lol | bonzo03 | |
30/6/2022 06:18 | A pretty solid addition https://www.insider. | swashbuck1er | |
25/5/2022 15:35 | Certainly did. https://ir.q4europe. | swashbuck1er | |
23/5/2022 06:31 | Blimey he is buying a lot of shares..... | pilkersa | |
20/5/2022 06:33 | Contracts keep coming. Rerate imminent.... | pilkersa |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions